|
Jul 18
|
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
|
|
Jul 18
|
Medical Filtration Company Benchmark Report 2025 | Merck KGaA, 3M, and Danaher Strengthen Medical Filtration Market Leadership Through Strategic Expansions, Spin-Offs, and Mergers
|
|
Jul 18
|
Microfiltration Membranes Company Evaluation Report 2024-2025 | Merck and Veolia Lead in Microfiltration Market with Strategic Moves
|
|
Jul 17
|
Sustainability Driving Global Innovation: Highlights From MilliporeSigma at Sustainability LIVE Chicago 2025
|
|
Jul 16
|
G-Protein Coupled Receptor (GPCR) Targeting Technologies Market on the Rise
|
|
Jul 15
|
MilliporeSigma Launches AAW™ Workstation to Advance Lab Automation
|
|
Jul 2
|
Merck concludes SpringWorks acquisition for $3.4bn
|
|
Jul 1
|
Merck Foundation Chairman, CEO, and 14 First Ladies Inaugurate the 7th Edition of Merck Foundation First Ladies Initiative - MFFLI Summit in Dubai
|
|
Jul 1
|
Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business
|
|
May 30
|
ASCO25: Merck KGaA’s ADC shows safety and tolerability in colorectal cancer trial
|
|
May 28
|
ASCO25: Merck KGaA to seek approval of TGCT drug after Phase III success
|
|
Feb 19
|
New CEOs to join Merck KGaA’s executive board
|
|
Feb 11
|
Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics
|
|
Feb 11
|
Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK
|
|
Feb 10
|
SpringWorks Stock Jumps More Than 30% on News of Possible Deal
|
|
Feb 10
|
Sector Update: Health Care Stocks Softer Late Afternoon
|
|
Feb 10
|
Germany's Merck in advanced talks to acquire US biotech firm SpringWorks
|
|
Feb 5
|
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
|
|
Jan 24
|
Merck and Opentrons to automate assay kits on custom workstation
|